Icon Group – Annual Research Report

Dr Paul Eliadis AM is the Co-Founder of Icon Group, Australia’s largest private provider of oncology clinical trials. Last month on International Clinical Trials Day, Icon Group released their first Annual Research Report. This is a fascinating report that details even through the Covid-19 pandemic, Icon Group’s research portfolio continued to grow. Throughout 2020, Icon Group saw record trial recruitment, increased tele-trials and the publication of milestone oncology trials!

Dr Paul Eliadis AM is proud to be involved in both haematology and medical oncology clinical trials and research opportunities that will provide new hope to patients and he looks forward to the year ahead for Icon Group.

You can find the 2020 Annual Research Report for Icon Group on their website by clicking here.

 

 

More About Dr Paul Eliadis AM

With over 35 years experience in Clinical Haematology and Oncology,
Dr Paul Eliadis is at the peak of his career. As a founder of Haematology and Oncology Clinics of Australia (HOCA), Dr Eliadis has and continues to support medical research that explores promising opportunities in cancer care.

The devotion to his profession extends from Medicine to an appreciation for the arts, ancient history and the classics. More recently, his support through a generous donation to the University of Queensland, has led to the creation of the Chair of Ancient History and the Classics within the newly named School for Historical and Philosophical Inquiry.

 

Dr Paul Eliadis

 

Stay Updated With Dr Paul Eliadis AM

Want to stay updated on the latest news and thoughts from Dr Paul Eliadis AM and his work in Clinical Haematology and Oncology? You can click here to follow Dr Paul Eliadis AM on LinkedIn. Dr Paul Eliadis’ official site here is also a great place to stay updated on the latest news on Dr Paul Eliadis AM.